Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) - TA4

Department of Defense · DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA) · Special Notice · DARPA-SN-26-91

posted 11 June 2026 · closed 29 June 2026 · NAICS 541714 · PSC AC12

Summary

DARPA is seeking support to commercialize technologies developed under its Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) program. The notice highlights the goal of moving these biomedical innovations toward market adoption as part of the agency’s Biological Technologies initiative.

View the official notice ↗

Want to know why the government is buying what they buy? Subscribe to the OODA Daily Pulse

The OODA Daily Pulse Report provides a detailed summary of the top technology, cybersecurity and global risks of the day. Our analysts curate stories, articles and insights from hundreds of vetted sources to inform your decisions and our research team provides long form context on topics destined to be of importance. Delivered free to your inbox five days a week at 10:00am.